Jump to content

Alpha-2 adrenergic receptor: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Flikr (talk | contribs)
m External link added
Line 72: Line 72:


[[es:Receptor adrenérgico alfa 2]]
[[es:Receptor adrenérgico alfa 2]]

==External links==
* {{cite web | url = http://www.iuphar-db.org/GPCR/ChapterMenuForward?chapterID=1274 | title = Adrenoceptors | accessdate = | author = | authorlink = | coauthors = | date = | format = | work = IUPHAR Database of Receptors and Ion Channels | publisher = International Union of Basic and Clinical Pharmacology | pages = | language = | archiveurl = | archivedate = | quote = }}

Revision as of 11:41, 25 November 2008

The α2 receptor is a type of adrenergic receptor.

Effect

The α2 receptor has several, general, functions in common with other α-receptors, but also has individual effects.

General

Common (or still unspecified) effects include:

Individual

Individual actions of the α2 receptor include:

Mechanism

A G protein - Gi renders adenylate cyclase inactivated, resulting in decrease of cAMP.

The relaxation of gastrointestinal tract motility is by presynaptic inhibition[5], where transmitters inhibit further release by homotropic effects.

Agonists

Epinephrine has higher affinity for the alpha-2 receptor than has norepinephrine, which, in turn, has much higher affinity than has isoprenaline.[5] Other agonists include:

* denotes selective agonists to the receptor.

      • Clonidine is an Alpha 2 Agonist ; initially thought act via postsynaptic Alpha 2 receptors --> reduced NE discharge. However! It binds to imidazoline receptors with a much greater affinity than Alpha 2s . Imidazoline Receptors occur in the Nucleus Tractus Solitarius & Ventrolateral Medulla. Clonidine is now thought to decrease BP via this central mechanism. ***

Antagonists

(Alpha blockers)

* denotes selective agonists to the receptor.

Types

There are three types of α2 receptors: ADRA2A, ADRA2B, ADRA2C.

See also

References

  1. ^ Goodman Gilman, Alfred. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Tenth Edition. McGraw-Hill (2001): Page 140.
  2. ^ Woodman OL, Vatner SF (1987). "Coronary vasoconstriction mediated by α1- and α2-adrenoceptors in conscious dogs". Am. J. Physiol. 253 (2 Pt 2): H388–93. PMID 2887122.
  3. ^ Elliott J (1997). "Alpha-adrenoceptors in equine digital veins: evidence for the presence of both α1 and α2-receptors mediating vasoconstriction". J. Vet. Pharmacol. Ther. 20 (4): 308–17. doi:10.1046/j.1365-2885.1997.00078.x. PMID 9280371.
  4. ^ Sagrada A, Fargeas MJ, Bueno L (1987). "Involvement of α1 and α2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat". Gut. 28 (8): 955–9. doi:10.1136/gut.28.8.955. PMID 2889649.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ a b c d e f g Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 163
  6. ^ Wright EE, Simpson ER (1981). "Inhibition of the lipolytic action of beta-adrenergic agonists in human adipocytes by alpha-adrenergic agonists". J. Lipid Res. 22 (8): 1265–70. PMID 6119348.
  7. ^ a b Fitzpatrick, David; Purves, Dale; Augustine, George (2004). "Table 20:2". Neuroscience (Third Edition ed.). Sunderland, Mass: Sinauer. ISBN 0-87893-725-0. {{cite book}}: |edition= has extra text (help); Cite has empty unknown parameter: |1= (help)CS1 maint: multiple names: authors list (link)
  8. ^ Khan ZP, Ferguson CN, Jones RM (1999). "alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role". Anaesthesia. 54 (2): 146–65. doi:10.1046/j.1365-2044.1999.00659.x. PMID 10215710.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ^ online-medical-dictionary.org
  • "Adrenoceptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)